NCT02132988View on ClinicalTrials.gov

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

PHASE2UnknownINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2018

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL

OPT-822/OPT-821

Trial Locations (1)

104

RECRUITING

Mackay Memorial Hospital, Taipei

Sponsors

Collaborators (1)

OBI Pharma, Inc

All Listed Sponsors

collaborator

OBI Pharma, Inc

INDUSTRY

lead

Mackay Memorial Hospital

OTHER